Posts Tagged ‘SGEN’

MomentumOptionsTrading.com Profit Alert (SGEN) for 11/7/2011

10:05am (EST) For those of you who use our cell phone alerts and Twitter updates, it’s time to take action again.  Seattle Genetics (SGEN, $17.50, down $0.51) is down to another 3% following Friday’s plunge below $20.  Our put options from early October have finally paid off as they areRead more

More

Wall Street, Seattle Genetics (SGEN) Pop, Then Drop

12:55pm (EST) The market is getting a lift today as the bulls push resistance following a 4-week losing streak but the major indexes are off their highs.  There hasn’t been any major headline news, negative that is, and economic gibberish doesn’t hit the tape until Tuesday which has given theRead more

More

Here Comes the Kitchen Sink

9:00am (EST) We mentioned yesterday the bulls looked as though they were going to go for broke. The market was at critical levels to start the week and Monday it appeared it was the bears, not the bulls that had the upper hand and the momentum.  Heck, the bears even had theRead more

More

Google (GOOG) Pushes 6 Bills, Seattle G (SEGN) Under $20

9:00am (EST) Things started off well for the bulls as better-than-expected earnings and so-so economic news provided a little pop on Thursday’s open.  However, as the day progressed, the bears took control to make it 3-to1 for the week as the market finished lower and the S&P Volatility Index (VIX,Read more

More

Seattle Genetics (SGEN) Update

1:15pm (EST) We wanted to give a quick update on Seattle Genetics (SGEN, $20.33, HALTED) as we have just learned the FDA committee has voted 10-0 in favor of one of its two drugs with another meeting scheduled this afternoon to review the other.  So far, so good…   ]]>

More

Seattle Genetics (SGEN) Halted; Google (GOOG) Earnings Due

12:25pm (EST) The bulls are trying to even things up for the week but are having trouble holding the gains off the open and still have a ways to go to get back to even.  JPMorgan (JPM, $40.77, up $1.15) provided some enthusiasm this morning after beating Wall Street’s expectationsRead more

More

Tuesday’s Tidbits

9:00am (EST) The bulls stampeded out of Wall Street’s gate at the start of Monday’s trading session on news that America’s most wanted terrorist, Osama Bin Laden, had been killed by U.S. military.  However, the euphoria only lasted until lunchtime before the bears made their presence known.  The market was able to extendRead more

More

Seattle Genetics (SGEN) Making Noise

1:05pm (EST) The bulls are pushing resistance once again after a number of companies beat earnings expectations which has helped offset weaker-than expected economic data.  Although the market has moved slightly below its session highs, the momentum is there for the bulls to close above our price targets. The CommerceRead more

More

MomentumOptionsTrading.com Weekly Wrap for 12/26/10

5:30pm (EST) 1.  Market Summary 2.  Seattle Genetics (SGEN) – Superior Product Leads to Value 3.  Earnings 4.  Weekly Wrap Portfolio Update   5.  Week Ahead = = = = = = = = = = = = = = =   1. Market Summary The bulls continued their merry wayRead more

More

CFTC Disclosure:

GOVERNMENT REGULATIONS REQUIRE DISCLOSURE OF THE FACT THAT WHILE THESE METHODS MAY HAVE WORKED IN THE PAST, PAST PERFORMANCE IS NOT NECESSARILY INDICATIVE OF FUTURE PERFORMANCE. WHILE THERE IS A POTENTIAL FOR PROFITS THERE IS ALSO A RISK OF LOSS. A LOSS INCURRED IN CONNECTION WITH Momentum Options Trading, LLC CAN BE SIGNIFICANT. YOU SHOULD THEREFORE CAREFULLY CONSIDER WHETHER TRADING IS SUITABLE FOR YOU IN LIGHT OF YOUR FINANCIAL CIRCUMSTANCE. THERE IS SUBSTANTIAL RISK IN TRADING. A LOSS INCURRED IN CONNECTION WITH FUTURES TRADING CAN BE SIGNIFICANT. WE MAKE NO CLAIM REGARDING PAST OR FUTURE PERFORMANCE. WE MERELY TRACK EVERY TRADE AND SHOW THE PERFORMANCE OF ALL TRADES THE SYSTEM OR NEWSLETTER PRODUCES. SIMULATED TRADING IS DIFFERENT THAN TRADING REAL MONEY. HYPOTHETICAL RESULTS ARE NOT REAL RESULTS. PLEASE CONTACT YOUR BROKER ABOUT THE RISK OR TRADING STOCKS, OPTIONS OR FUTURES. ALL COMMUNICATIONS ARE OPINIONS NOT ADVICE.

CFTC RULE 4.41 – HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.